ellipticine has been researched along with Benign Neoplasms, Brain in 4 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cytotoxicity of ellipticine to neuroblastomas was increased by pre-treating these cells with VPA or TSA." | 7.77 | Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. ( Dvorakova, M; Eckschlager, T; Frei, E; Göttlicherova, M; Hrabeta, J; Hrebackova, J; Kizek, R; Kopejtkova, B; Moserova, M; Poljakova, J; Stiborova, M, 2011) |
| "The cytotoxicity of ellipticine to neuroblastomas was increased by pre-treating these cells with VPA or TSA." | 3.77 | Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. ( Dvorakova, M; Eckschlager, T; Frei, E; Göttlicherova, M; Hrabeta, J; Hrebackova, J; Kizek, R; Kopejtkova, B; Moserova, M; Poljakova, J; Stiborova, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acton, EM | 1 |
| Narayanan, VL | 1 |
| Risbood, PA | 1 |
| Shoemaker, RH | 1 |
| Vistica, DT | 1 |
| Boyd, MR | 1 |
| Jurayj, J | 1 |
| Haugwitz, RD | 1 |
| Varma, RK | 1 |
| Paull, KD | 1 |
| Barrett, JF | 1 |
| Cushman, M | 1 |
| Banerjee, S | 1 |
| Pabbathi, A | 1 |
| Sekhar, MC | 1 |
| Samanta, A | 1 |
| Poljakova, J | 1 |
| Hrebackova, J | 1 |
| Dvorakova, M | 1 |
| Moserova, M | 1 |
| Eckschlager, T | 1 |
| Hrabeta, J | 1 |
| Göttlicherova, M | 1 |
| Kopejtkova, B | 1 |
| Frei, E | 1 |
| Kizek, R | 1 |
| Stiborova, M | 1 |
4 other studies available for ellipticine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Anticancer specificity of some ellipticinium salts against human brain tumors in vitro.
Topics: Brain Neoplasms; Drug Evaluation, Preclinical; Ellipticines; Humans; Structure-Activity Relationship | 1994 |
Design and synthesis of ellipticinium salts and 1,2-dihydroellipticines with high selectivities against human CNS cancers in vitro.
Topics: Brain Neoplasms; Drug Design; Drug Evaluation, Preclinical; Ellipticines; Humans; Structure-Activity | 1994 |
Dual fluorescence of ellipticine: excited state proton transfer from solvent versus solvent mediated intramolecular proton transfer.
Topics: Antineoplastic Agents; Brain Neoplasms; Ellipticines; Fluorescence; Humans; Hydrogen Bonding; Hydrop | 2011 |
Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; DNA Damage; Dose-Response | 2011 |